Sofwave Medical Reports Preliminary, Unaudited, Fourth Quarter and Full Fiscal Year 2025 Topline Financial Results

Core Insights - Sofwave Medical Ltd announced preliminary financial results for Q4 and the full fiscal year ending December 31, 2025, indicating significant revenue growth [1][7]. Financial Performance - Q4 2025 revenue is projected to be between $28.6 million and $28.9 million, representing an increase of approximately 57% compared to Q4 2024, which had revenue of about $18.3 million [7]. - Full fiscal year 2025 revenue is expected to be between $87.3 million and $87.6 million, reflecting a 46% increase from approximately $59.7 million in the previous fiscal year [7]. - As of December 31, 2025, cash and cash equivalents, including a short-term restricted deposit, are expected to be $35.2 million, up from $26.5 million as of September 30, 2025 [7]. Strategic Developments - The Board of Directors approved management to prepare and submit a draft Form F-1 Registration Statement to the U.S. Securities and Exchange Commission (SEC) for a potential public offering in the United States [3].